National Pharmaceutical Pricing Authority (NPPA) fixed the ceiling price of 890 formulations in India. Out of which, about 86 formulations were anti-cancer, listed in Schedule I of DPCO, 2013 in India as of December 2022. Furthermore, the ceiling prices of about 358 medicines were fixed in that time period.
Number of formulations under National Pharmaceutical Pricing Authority(NPPA) ceiling prices in India as of December 2022, by category
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Statistics on
About the industry
10
- Basic Statistic Top pharmaceutical companies in Sweden by sales 2022
- Premium Statistic Top pharmaceutical companies in Argentina 2014 by revenue
- Basic Statistic Employment at select top pharmaceutical companies in Denmark 2023
- Premium Statistic Revenue from pharmaceutical manufacturer in Denmark 2009-2023
- Premium Statistic Merck KGaA's number of employees 1999-2023
- Premium Statistic Merck & Co.'s top-selling drugs 2023
- Basic Statistic producer price index of chemical and pharmaceutical products in Norway 2008-2023
- Basic Statistic Net export value of pharmaceuticals from Sweden 2012-2022
- Basic Statistic Import value of pharmaceuticals into Sweden 2012-2022
- Basic Statistic Leading pharmaceutical companies in Norway 2021, by revenue
About the region
10
- Premium Statistic KAPL production value FY 2014-2022
- Premium Statistic KAPL sales value FY 2014-2022
- Premium Statistic BCPL's production value FY 2014-2023
- Premium Statistic BCPL net profit FY 2014-2023
- Premium Statistic Hindustan Antibiotics production value of FY 2014-2023
- Premium Statistic HAL sales turnover FY 2014-2023
- Premium Statistic HAL net profit FY 2014-2023
- Premium Statistic RDPL total turnover FY 2017-2019
- Premium Statistic BCPL turnover 2014-Q3 2018
- Premium Statistic Quarterly percentage change of raw materials in pharmaceuticals industry India 2016
Selected statistics
10
- Basic Statistic Merck & Co total assets 2009-2023
- Premium Statistic Merck & Co - expenditure on research and development 2006-2023
- Basic Statistic Merck & Co cash dividends declared 2006-2023
- Premium Statistic Sales of Johnson & Johnson 2006-2023 by region
- Premium Statistic Pfizer's revenues in the U.S. and abroad 2009-2023
- Premium Statistic Johnson & Johnson's number of employees 2004-2023
- Premium Statistic Sales of Johnson & Johnson worldwide 2011-2023, by segment
- Premium Statistic Global pharmaceutical pipeline by therapy area 2013-2017
- Basic Statistic Sanofi's total assets 2007-2023
- Premium Statistic AstraZeneca's expenditure on research and development 2006-2023
Other regions
10
- Basic Statistic Worldwide Rx drug sales excluding generics and orphan drugs 2012-2026
- Premium Statistic Market share of Celltrion's Remsima in Europe Q1 2015-Q2 2018
- Premium Statistic Top specialty drug pharmacies in the U.S. by revenue 2023
- Premium Statistic Pharmaceutical market size Japan 2008-2015
- Premium Statistic Latin America: main pharmacies 2017, by number of stores
- Premium Statistic Brazil: net revenue of Bayer 2013-2017
- Premium Statistic Venezuela: pharma industry market value 2008-2017
- Premium Statistic Saudi Pharmaceutical Industries and Medical Appliances Corporation revenue 2012-2018
- Premium Statistic Main pharmacies in Mexico 2019, by size
- Premium Statistic Revenue of the top ten pharmaceutical companies in France 2021
Related statistics
10
- Premium Statistic Quarterly percentage change of salaries in pharmaceuticals industry India 2016
- Premium Statistic Net profit of major pharma companies India 2024
- Premium Statistic Cipla's income from operations FY 2014-2023
- Premium Statistic Cipla's API revenue FY 2017-2023
- Premium Statistic GSK Pharmaceuticals' remuneration of executive directors in India 2023
- Premium Statistic GSK Pharmaceuticals' book value per share India FY 2015-2023
- Premium Statistic GSK Pharmaceuticals' market price of shares at NSE India FY 2023, by month
- Premium Statistic GSK Pharmaceuticals' net profit India FY 2015-2023
- Premium Statistic GSK Pharmaceuticals' revenue share from operations in India FY 2015-2023
- Premium Statistic GSK Pharmaceuticals' profit before tax in India FY 2015-2023
Further related statistics
10
- Pfizer's ad spending 2006-2023
- AstraZeneca's revenue from top product Pulmicort 2006-2023
- Revenue of Sinopharm 2011-2022, by category
- Number of employees at Sinopharm 2011-2022
- Annual revenue of Sinopharm 2010-2022
- Annual revenue of Shanghai Pharmaceuticals 2011-2022
- M&A capacities - changes for the global pharma industry 2008-2015
- Expenditure worldwide on diabetes by market 2013-2018
- Chinese insulin market distribution: leading companies 2011
- U.S. insulin market distribution: leading companies 2011
Further Content: You might find this interesting as well
Statistics
- Pfizer's ad spending 2006-2023
- AstraZeneca's revenue from top product Pulmicort 2006-2023
- Revenue of Sinopharm 2011-2022, by category
- Number of employees at Sinopharm 2011-2022
- Annual revenue of Sinopharm 2010-2022
- Annual revenue of Shanghai Pharmaceuticals 2011-2022
- M&A capacities - changes for the global pharma industry 2008-2015
- Expenditure worldwide on diabetes by market 2013-2018
- Chinese insulin market distribution: leading companies 2011
- U.S. insulin market distribution: leading companies 2011
Department of Pharmaceuticals (India). (February 21, 2023). Number of formulations under National Pharmaceutical Pricing Authority(NPPA) ceiling prices in India as of December 2022, by category [Graph]. In Statista. Retrieved June 01, 2024, from https://www.statista.com/statistics/1370570/india-number-of-formulations-under-nppa-ceiling-prices-by-category/
Department of Pharmaceuticals (India). "Number of formulations under National Pharmaceutical Pricing Authority(NPPA) ceiling prices in India as of December 2022, by category." Chart. February 21, 2023. Statista. Accessed June 01, 2024. https://www.statista.com/statistics/1370570/india-number-of-formulations-under-nppa-ceiling-prices-by-category/
Department of Pharmaceuticals (India). (2023). Number of formulations under National Pharmaceutical Pricing Authority(NPPA) ceiling prices in India as of December 2022, by category. Statista. Statista Inc.. Accessed: June 01, 2024. https://www.statista.com/statistics/1370570/india-number-of-formulations-under-nppa-ceiling-prices-by-category/
Department of Pharmaceuticals (India). "Number of Formulations under National Pharmaceutical Pricing Authority(Nppa) Ceiling Prices in India as of December 2022, by Category." Statista, Statista Inc., 21 Feb 2023, https://www.statista.com/statistics/1370570/india-number-of-formulations-under-nppa-ceiling-prices-by-category/
Department of Pharmaceuticals (India), Number of formulations under National Pharmaceutical Pricing Authority(NPPA) ceiling prices in India as of December 2022, by category Statista, https://www.statista.com/statistics/1370570/india-number-of-formulations-under-nppa-ceiling-prices-by-category/ (last visited June 01, 2024)
Number of formulations under National Pharmaceutical Pricing Authority(NPPA) ceiling prices in India as of December 2022, by category [Graph], Department of Pharmaceuticals (India), February 21, 2023. [Online]. Available: https://www.statista.com/statistics/1370570/india-number-of-formulations-under-nppa-ceiling-prices-by-category/